2012
DOI: 10.3109/03008207.2012.711867
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Direct Factor Xa Inhibitor (Rivaroxaban) on the Human Osteoblastic Cell Line SaOS2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
34
0
8

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(43 citation statements)
references
References 35 publications
1
34
0
8
Order By: Relevance
“…Preclinical studies have come to differing conclusions. Klüter et al (16) (17). Rivaroxaban inhibited the stimulation of cell proliferation, energy metabolism, alkaline phosphatase specific activity and mRNA modulation by a variety of hormones, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…Preclinical studies have come to differing conclusions. Klüter et al (16) (17). Rivaroxaban inhibited the stimulation of cell proliferation, energy metabolism, alkaline phosphatase specific activity and mRNA modulation by a variety of hormones, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…Gigi et al evaluated the factor Xa inhibitor rivaroxaban using an in vitro cell culture model from the human female osteoblastic cell line SaOS2. 31 Cells at subconfluence were treated for 24 hours with different concentrations of rivaroxaban and analyzed for DNA synthesis and creatine kinaseand alkaline phosphatase-specific activities. Treatment was continued for 21 days for analyzing mineralization.…”
Section: Strategies For Preventing Osteoporosis In Patients On Vitamimentioning
confidence: 99%
“…Osteoblastic mineralization was unaffected, indicating that rivaroxaban inhibits the first stage of bone formation but does not exert effects in later stages (bone mineralization), thus producing a transient inhibition of bone formation. 31 The same authors investigated the effects of rivaroxaban on SaOS2 response to osteoblast-modulating hormones. 32 At subconfluence cells were treated with estradiol-17β, phytoestrogens, estrogen receptor α (ERα) and β (ERβ) agonists, parathyroid hormone, and several vitamin D metabolites and analogs, in the presence or in the absence of rivaroxaban for 24 hours.…”
Section: Strategies For Preventing Osteoporosis In Patients On Vitamimentioning
confidence: 99%
“…Recent work from Israel 11 showed no delay in bone healing as well as no affection of cell mineralization after the administration of high doses of Rivaroxaban. This phenomenon can be explained by the effect of the drug being transient or by an adaptation of the cells to the inhibiting effect and compensation by some other mechanism 12,25 . It seems that the role of hematoma (post-traumatic or post-surgical) is essential in fracture healing as well as in osseointegration.…”
Section: Discussionmentioning
confidence: 99%